Lyl-1 Activators
Lyl-1, short for Lymphoblastic leukemia-derived sequence 1, is a transcription factor belonging to the basic helix-loop-helix (bHLH) family, playing a critical role in hematopoiesis and lymphocyte development. Activators of Lyl-1 are compounds or molecules that enhance the expression or activity of this transcription factor, thereby influencing the genetic programs it governs.
The mechanism of action for Lyl-1 activators can vary, but they generally work by either upregulating the expression of the Lyl-1 gene, stabilizing the Lyl-1 protein, or enhancing its ability to bind DNA and promote the transcription of target genes. These activators could involve small molecules, peptides, or other forms of biological agents that interact specifically with Lyl-1 or its regulatory pathways. In the context of hematopoietic stem cells (HSCs) and progenitor cells, Lyl-1 activators could play a pivotal role in promoting self-renewal and differentiation processes critical for the maintenance of blood cell lineages. By activating Lyl-1, these compounds may support the expansion of HSCs or the generation of specific types of blood cells, which could have implications for research in regenerative medicine.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Utilized to activate protein kinase C (PKC), indirectly facilitating Lyl-1 activation by modulating T-cell signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Elevates intracellular calcium levels, indirectly promoting Lyl-1 activation by modulating downstream signaling pathways essential for T-cell development. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Acts as an inhibitor of calcineurin, a protein crucial for T-cell activation, indirectly triggering Lyl-1 activation by impeding the calcineurin-mediated signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway, an important signaling cascade in T-cell development, indirectly prompting Lyl-1 activation by disrupting mTOR-related processes. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Affect intracellular calcium signaling, indirectly fostering Lyl-1 activation by modulating calcium-dependent processes critical in T-cell development. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Block the JAK-STAT signaling pathway involved in cytokine receptor signaling, indirectly propelling Lyl-1 activation by disrupting this essential signaling cascade. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibit the NF-κB pathway, which plays a role in T-cell activation and Lyl-1 activation by affecting the NF-κB-dependent processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Block the TGF-β signaling pathway, indirectly stimulating Lyl-1 activation by interfering with the TGF-β-related mechanisms crucial for T-cell differentiation. | ||||||